Live from the NIH registry
Studies recruiting near Vancouver right now
Top 25 of 1,021 recruiting studies, sorted by proximity — each links to its official registry page
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
Caregiver Burden
N/A
Interventional 238 participants sought
Oregon Health & Science University, Layton Aging and Alzheimer's Disease Research Center — Portland, Oregon (8.7 mi)
· Sponsor: Oregon Health and Science University
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Regeneron Pharmaceuticals
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Oregon Health & Science University, Knight Cancer Institute — Portland, Oregon (8.7 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Eli Lilly and Company
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
PeaceHealth Southwest Medical Center — Vancouver, Washington (3.1 mi)
· Sponsor: SWOG Cancer Research Network
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Shockwave Medical, Inc.
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
Providence St. Vincent Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Joseph Broderick, MD
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
N/A
Observational 3,000 participants sought
Oregon Clinic — Portland, Oregon (8.7 mi)
· Sponsor: Duke University
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
OHSU Dept of Nephrology — Portland, Oregon (8.7 mi)
· Sponsor: Novartis Pharmaceuticals
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Asthma, Pulmonary Function
N/A
Observational 225 participants sought
Oregon Health and Science University (OHSU) — Portland, Oregon (8.7 mi)
· Sponsor: Oregon Health and Science University
Treatment of the Biceps With Concomitant Supraspinatus Tears
Supraspinatus Tear
N/A
Interventional 180 participants sought
Oregon Health & Science University — Portland, Oregon (8.7 mi)
· Sponsor: La Tour Hospital
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 1
Interventional 126 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente Northwest — Portland, Oregon (8.7 mi)
· Sponsor: NRG Oncology
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Randall Children's Hospital — Portland, Oregon (8.7 mi)
· Sponsor: Giselle Sholler
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
Actinic Keratosis
Phase 3
Interventional 160 participants sought
Oregon Dermatology and Research Center — Portland, Oregon (8.7 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Metastatic Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma
Phase 3
Interventional 1,524 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
PeaceHealth Southwest Medical Center — Vancouver, Washington (3.1 mi)
· Sponsor: SWOG Cancer Research Network
IVIG for Infection Prevention After CAR-T-Cell Therapy
Hematologic Malignancies
Phase 2
Interventional 150 participants sought
Oregon Health and Science University (OHSU) Knight Cancer Institute — Portland, Oregon (8.7 mi)
· Sponsor: Fred Hutchinson Cancer Center
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection
Viral Pneumonia
Phase 2
Interventional 550 participants sought
Oregon Health & Science University (OHSU) — Portland, Oregon (8.7 mi)
· Sponsor: Synairgen Research Ltd.
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Acute Myeloid Leukemia
Phase 1
Interventional 40 participants sought
OHSU Knight Cancer Institute — Portland, Oregon (8.7 mi)
· Sponsor: OHSU Knight Cancer Institute
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Providence Portland Medical Center — Portland, Oregon (8.7 mi)
· Sponsor: National Cancer Institute (NCI)
Hearing Aids for Veterans With Functional Hearing Difficulties
Auditory Processing Disorder
N/A
Interventional 142 participants sought
VA Portland Health Care System, Portland, OR — Portland, Oregon (8.7 mi)
· Sponsor: VA Office of Research and Development
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 220 participants sought
Oregon Health and Science University — Portland, Oregon (8.7 mi)
· Sponsor: Circle Pharma
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
IgA Nephropathy
Phase 4
Interventional 60 participants sought
Oregon Health & Science University (OHSU) - Nephrology and Hypertension Clinic — Portland, Oregon (8.7 mi)
· Sponsor: Calliditas Therapeutics AB